BCL2 and Miyoshi myopathy: Furthermore, CXCL12 was found to increase the expression of survivin, BCL2 and the multidrug resistance transporter ABCC1 in MM cells to enhance anti-apoptotic and detoxification ability, therefore promoting MM cells survival 122.